Cipla Quality Chemical Industries Ltd

Equities

CQCIL

UG0000000196

End-of-day quote UGANDA SECURITIES EXCHANGE Other stock markets
- ^UGX	-

2023	Africa Capitalworks SSA 3 completed the acquisition of 51.18% stake in Cipla Quality Chemical Industries Limited from Cipla (EU) Limited and Meditab Holdings Ltd. for $25 million.	CI
2023	Cipla Quality Chemical Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Cipla Quality Chemical Industries Limited has completed an IPO in the amount of UGX 168.566495 billion.

September 14, 2018 at 12:00 am EDT

Cipla Quality Chemical Industries Limited has completed an IPO in the amount of UGX 168.566495 billion. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 657,179,319 PriceRange: UGX 256.5 Transaction Features: Regulation S; Sponsor Backed Offering

Latest news about Cipla Quality Chemical Industries Ltd

Africa Capitalworks SSA 3 completed the acquisition of 51.18% stake in Cipla Quality Chemical Industries Limited from Cipla (EU) Limited and Meditab Holdings Ltd. for $25 million.	Nov. 13	CI
Cipla Quality Chemical Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-25	CI
Africa Capitalworks SSA 3 entered into a share purchase agreement to acquire a 51.18% stake in Cipla Quality Chemical Industries Limited from Cipla (EU) Limited and Meditab Holdings Ltd. for $30 million.	23-03-13	CI
Cipla Quality Chemical Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-26	CI
Sensex, Nifty close higher as vaccine fuels recovery hopes	20-11-10	RE
2,169,033,211 Ordinary Shares of Cipla Quality Chemical Industries Limited are subject to a Lock-Up Agreement Ending on 17-SEP-2020.	20-09-16	CI
Cipla Quality Chemical Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2020	20-06-15	CI
Quality Chemical Industries Ltd. Reports Earnings Results for the Full Year Ended March 31, 2019	19-07-04	CI
825,696,670 Ordinary Shares of Cipla Quality Chemical Industries Limited are subject to a Lock-Up Agreement Ending on 17-MAR-2019.	19-03-16	CI
Cipla Quality Chemical Industries Limited has completed an IPO in the amount of UGX 168.566495 billion.	18-09-14	CI
Cipla Quality Chemical Industries Limited has filed an IPO.	18-08-10	CI
Cipla Quality Mulls IPO	18-08-02	CI
Cipla Quality Chemical Industries Ltd Tremendous Strides in the Fight Against HIV/AIDS	18-06-13	CI
Meditab Holdings Limited acquired 14.5% stake in Quality Chemical Industries Limited for $15 million.	13-11-20	CI

Chart Cipla Quality Chemical Industries Ltd

Duration

Period

Chart Cipla Quality Chemical Industries Ltd

More charts

Company Profile

Cipla Quality Chemicals Industries Limited specializes in the manufacture and marketing of WHO prequalified drugs for the treatment of malaria, retrovirus-related infections and hepatitis B and C. Net sales break down by product family as follows: - drugs anti-malarial (77.2%); - drugs antiretroviral (22.4%); - drugs for the treatment of hepatitis B (0.1%); - other (0.3%). At the end of March 2020, the group had a production site in Uganda. Uganda accounts for 86,9% of net sales.

Sector

More about the company

Income Statement Evolution

More financial data